跳至主要内容
临床试验/NCT04409717
NCT04409717已完成不适用

Evaluation of the Long Term Efficacy of Endovascular Treatment of Type 2 Endoleaks

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
19
试验地点
1
主要终点
Recurrence rate of type II endoleaks treated with endovascular intervention

研究概览

简要总结

Endovascular treatment has become the first choice to repair abdominal aortic aneurym, but exposes patients to a risk of endoleaks. Although treatment of type 1 and 3 endoleaks has proven to prevent aneurysms from rupture, controversies remain about type 2 endoleaks. The investigators described the different techniques of type 2 endovascular repair, and their efficacy at short and long term..

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients treated for type II endoleaks by endovascular therapy

排除标准

  • 未提供

结局指标

主要结局

Recurrence rate of type II endoleaks treated with endovascular intervention

时间窗: 12 years

次要结局

  • Type of type II endoleaks treatment(12 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eric STEINMETZ

Professor

Centre Hospitalier Universitaire Dijon

研究点 (1)

Loading locations...

相似试验

Evaluation of the Long Term Efficacy of Endovascular... | 临床试验